BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)
| CAPS Rating |
|
|---|---|
| Open | $37.92 |
| Previous Close | $38.05 |
| Daily Range | $37.13 - $37.92 |
| 52-Week Range | $23.09 - $38.66 |
| Market Cap | $4.16B |
| P/E Ratio | 21.40 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,320,147 |
| Average Daily Volume | 0 |
BMRN
VS S&P 500 (SPY)
How do you think BMRN will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BMRN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BMRN News and Commentary
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape – NASDAQ
- Don't Get Too Worked Up Over BioMarin Pharmaceutical's Earnings – The Motley Fool
- Qiagen Expands with New Deals - Analyst Blog – NASDAQ
- JPMorgan Confab Kicks Off Biotech 2012 – Minyanville
- Too Early for a New Biotech Orphan? – The Motley Fool
- BioMarin's Facility Expansion Backed - Analyst Blog – NASDAQ
- As the Biotech Saying Goes... – The Motley Fool
- Pipeline Progress at BioMarin - Analyst Blog – NASDAQ
- Facility Expansion at BioMarin - Analyst Blog – NASDAQ
- Should You Get Out of BioMarin Pharmaceutical Before Next Quarter? – The Motley Fool
- The 8 Highest Potential Returns in Biotechnology – The Motley Fool
- Shire Enters a Crowded Market – The Motley Fool
- Give Avanir Some Time – The Motley Fool
- Is Alexion Pharmaceuticals the Perfect Stock? – The Motley Fool
- 2 Backdoor Biotech IPOs to Watch – The Motley Fool
- BioMarin Pharma Buys Irish Biologics Plant From Pfizer For $48.5 Million – SmartMoney
- Roundtable: The World's Best Biotechs – The Motley Fool
- The Significance of Raptor's Decision to Start With Orphan Disease Strategy – Minyanville
- Uncontrolled Crying Over AVANIR's Prescription Data? – The Motley Fool
- Top Biotech Picks by Hedge Fund and Mutual Fund Gurus Concentrated in the Sector – SeekingAlpha
RSS Headlines
Fool UK
